rawfin.tv
Enliven Therapeutics Director Sells 13,000 Shares After Option Exercise
MarketsstocksAI Generated

Enliven Therapeutics Director Sells 13,000 Shares After Option Exercise

By rawfin.tv Markets Desk||Updated |1 min read|AI-assisted · Methodology

Enliven Therapeutics (ELVN) director J. Scott Garland exercised options for 13,000 shares at $15.47 per share. He subsequently sold these shares.

ELVNInsider TradingStock OptionsDirector

Related Articles

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

Adidas Surges 37% to Record Q3 Profit, Lifts Full-Year Targets

stocks
EQT to Acquire Cleanaway Waste for $6.5 Billion

EQT to Acquire Cleanaway Waste for $6.5 Billion

stocks
S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

S&P 500 Breaches Key Support as AI Sell-Off Pressures Tech Sector

stocks
US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

US Chip Stocks Plunge 16% in Longest Losing Streak Since 2008

stocks